The Gender Association of the SIRT1 rs7895833 Polymorphism with Pediatric Obesity: A 3-Year Panel Study

Myoungsook Lee1, Serim Choi, Yunkyoung Lee

  • 1Department of Food and Nutrition, Sungshin Women's University, Seoul, Republic of Korea.

Insights

Sirtuin 1 (SIRT1) gene variations are linked to pediatric obesity in Korean children. This study found differences in obesity markers and metabolic health based on SIRT1 genotypes, with a notable gender disparity.

Area of Science:

  • Genetics and genomics
  • Pediatric health and nutrition
  • Metabolic disorders

Background:

  • Sirtuin 1 (SIRT1) is a longevity-associated gene with diverse functions.
  • Pediatric obesity is a growing public health concern with complex etiologies.
  • Genetic variations may influence an individual's susceptibility to obesity.

Purpose of the Study:

  • To investigate the association between Sirtuin 1 (SIRT1) gene variation and pediatric obesity.
  • To explore potential gender-specific effects of SIRT1 genotypes on obesity parameters and metabolic profiles in children.

Main Methods:

  • A longitudinal study followed 219 children (8-9 years old) for 3 years.
  • Obesity parameters (anthropometrics, lipids, insulin resistance) and nutrient intake were analyzed.
  • Genotyping was performed for the SIRT1 rs7895833 polymorphism (GG, GA, AA).

Main Results:

  • Obesity prevalence increased from 18.3% to 25.1% over the study period.
  • Children with GA+AA genotypes showed higher BMI and waist circumference compared to GG genotype.
  • Gender-specific effects were observed: boys showed differential lipid changes, while girls exhibited distinct insulin resistance improvements based on genotype.

Conclusions:

  • SIRT1 gene variation is associated with pediatric obesity in Korean children.
  • A significant gender difference was observed in the association between SIRT1 variation and metabolic health outcomes.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
336
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.8K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
31.6K